Home

Granules India Ltd EPS

Image

Granules India Ltd

NSE: GRANULES

EPS

₹ 19.75

Last updated on: Apr 17, 2025

Key Highlights

  • The Earning per Share of Granules India Ltd is ₹ 19.75 as of 17 Apr 25 .
  • The earning per share of Granules India Ltd changed from ₹ 1.98 to ₹ 4.85 over 7 quarters. This represents a CAGR of 66.85% .

Historical Earning per Share of Granules India Ltd

No data available

* All values are in

Company Fundamentals for Granules India Ltd

Market Cap

11,336 Cr

EPS

19.8

P/E Ratio (TTM)

23.7

P/B Ratio (TTM)

3.3

Day’s High

471.0

Day’s Low

457.3

DTE

0.3

ROE

14.2

52 Week High

724.55

52 Week Low

389.15

ROCE

16.9

Market Price of Granules India Ltd

1M

1Y

3Y

5Y

Monitoring Granules India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
17 Apr 2025467.4
16 Apr 2025462.6
15 Apr 2025464.35
11 Apr 2025452.1
09 Apr 2025431.2
08 Apr 2025444.65
07 Apr 2025436.8
04 Apr 2025457.2
03 Apr 2025491.25
02 Apr 2025482.95

SWOT Analysis Of Granules India Ltd

Strength

4

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Granules India Ltd

Asset Value vs Market Value of Granules India Ltd

Market Value

11,336

Asset Value

Value addition

2.7 X

3,064

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Granules India Ltd11336
Sun Pharmaceutical Industries Ltd420136
Divis Laboratories Ltd149680
Cipla Ltd122390
Torrent Pharmaceuticals Ltd110154
Mankind Pharma Ltd106555

Historical Market Cap of Granules India Ltd

No data available

* All values are in crore

Historical Revenue of Granules India Ltd

No data available

* All values are in crore

Historical EBITDA of Granules India Ltd

No data available

* All values are in crore

Historical Net Profit of Granules India Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Granules India Ltd News Hub

Granules India Ltd soars 1.63%, up for third straight session

Granules India Ltd rose for a third straight session today. The stock is quoting at Rs 686.45, up 1.

Read more

21 Aug 24

Granules Pharmaceuticals receives USFDA approval for Glycopyrrolate Oral Solution

Granules India announced today that the U.S. Food and Drug Administration (FDA) has approved its Abb

Read more

20 Aug 24

Granules India rises on USFDA nod for oral drug Glycopyrrolate

The ANDA has been filed by Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary o

Read more

20 Aug 24

Granules India receives US FDA nod for depression treatment drug Trazodone

It is bioequivalent and therapeutically equivalent to the reference listed drug Desyrel Tablets of P

Read more

09 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

July 2021

PPT

Jan 2021

PPT

FAQs for EPS of Granules India Ltd

What is the EPS of Granules India Ltd stock?

The Earnings Per Share (EPS) of Granules India Ltd is 19.75. An EPS is the amount of net income attributed to each share of a common stock.

How is Granules India Ltd EPS calculated?

The EPS of Granules India Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Granules India Ltd report its EPS?

Granules India Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Granules India Ltd EPS?

Factors that influence the EPS of Granules India Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Granules India Ltd EPS growth indicate future performance?

Yes, consistent growth in Granules India Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions